Barrera et al, 200530 | Thoracotomy/ lung cancer resection | 300 | PS | 30 days | Yes | No | No significant increase in pulmonary complications among those who quit within 2 months and CS. Incidence of pneumonia was lower in NS compared to PS or CS but there was no significant difference between PS and CS |
Total complications
|
| 300 | <2 mths (13%) | PS = 19% |
>2 mths (62%) | RQ = 23% |
CS (4%) | NS = 8% |
NS (21%) |
Pneumonia
|
PS = 10% |
RQ = 15% |
NS = 3% |
Atelectasis
|
PS = 5% |
RQ = 3% |
NS = 0% |
Pulmonary embolism
|
PS = 2% |
RQ = 3% |
NS = 2% |
Respiratory failure
|
PS = 1% |
RQ = 3% |
NS = 0% |
Mean length of stay
|
CS = 9 days |
PS = 8 days |
RQ = 8 days |
NS = 6 days |
Bluman et al, 199832 | General, orthopaedic, cardiac | 410 | PS (46%) | Not stated | Yes | No | CS had a 6×-increased risk of pulmonary complications. There was no significant increase in risk of pulmonary complications in PS in comparison to NS. Reducing cigarette consumption <1 month preoperatively did not reduce the risk of pulmonary complications |
Atelectasis or worsening
|
<1 wk | CS = 8% |
⩾1 wk <2 wks | PS = 7% |
⩾2 wks <4 wks | NS = 0% |
⩾1 mth |
Pulmonary infection
|
CS reduced <4 wks | CS = 3% PS = 1% N |
CS (34%) | S = 0% |
NS (20%) |
Mortality
|
CS = 1% |
PS = 1% |
NS = 0% |
Total PCs (95% CI) |
<1 wk = 3.5%; 10.6 (1.6 to 69.6) |
<2 wks = 7.1%; 4.7 (1.2 to 19.0) |
<4 wks = 7.8%; 4.0 (1.0 to 15.7) |
⩾1 mth = 6.4%; 14.2 (3.2 to 63.6) |
CS = 74.5% 1.0 |
|
Chang et al, 200033 | TRAM flap breast reconstruction | 718 | PS ⩽4 wks (67%) | Not stated | No | No | CS had a higher incidence of complications than NS with no significant differences between NS and PS. Heavier smokers had a higher overall complication risk than lighter smokers |
Overall flap complication
|
CS (13%) | CS = 31.1% |
NS (67%) | PS = 25.3% |
NS = 22.6% |
Goodwin et al, 200534 | Tissue expander/implant breast reconstruction | 515 | PS >4 wks (15%) | Not stated | No | No | There were significantly more complications in PS than NS. There was no significant difference in complication rates between PS and CS. There was an 80% increased risk of complications for each pack increase in cigarettes per day |
Wound infection
|
CS (11%) | CS = 9.1% |
NS (75%) | NS = 2.9% |
Total PCs
|
CS = 37.9% |
NS = 15.1% |
Hasdai et al, 199735 | Coronary revascularisation | 5437 | PS >6 mths (42%) | Up to 16 years (average 4.5 years) | No | No | Long-term risk of mortality was 44% greater in CS in comparison to PS. Cessation before or after surgery was beneficial | Mortality QPS = 1.2 (0.87–1.70) |
QPS (8%) | PS = 1.3 (1.14–1.57) |
CS (14%) | NS = 1.0 |
NS (37%) |
Myocardial infarction
|
QPS = 1.4 (0.64 to 3.11) |
PS = 1.28 (0.77 to 2.16) |
NS = 1.0 |
Severe angina
|
QPS = 0.91 (0.76 to 1.08) |
PS = 0.99 (0.90 to 1.09) |
NS = 1.0 |
|
Lavernia et al, 199936 | Unilateral arthroplasty of hip or knee | 202 | PS <6 weeks | Not stated | No | No | NS combined with PS had significantly shorter surgery duration and needed less anaesthesia than CS. NS combined with PS had significantly shorter surgery duration and needed less anaesthesia than CS |
Length of stay
|
CS (12%) | CS = 5.4±3.9 |
NS (88%) | PS = 5.3±2.7 |
NS = 5.1±2.6 |
Total PCs
|
CS = 16% |
PS = 26.2% |
NS = 21.5% |
Levin et al, 200437 | Onlay bone grafts, sinus lift | 128 | PS >6 mths | Not stated | No | No | Significantly higher incidence of postoperative complications in CS in comparison to NS. No significantly increased risk of complications in PS |
Total PCs
|
CS: | NS = 23.1% |
Mild <10 per day | CS = 50% |
Heavy ⩾10 per day | No data obtainable for PS |
NS* |
Moore et al, 200538 | Pelvic reconstructive surgery | 887 | PS ⩾1 mth (26%) | 1 mth | No | No | No significant difference in the incidence of postoperative complications in NS and PS | Total PCs PS = 26% |
NS (74%) | NS = 29% |
|
Myles et al, 200239 | Ambulatory Surgery | 489 | PS>28 days (24%) | 7 days | No | Yes | PS combined with NS had a significantly lower incidence of coughing, respiratory complications and wound infection than CS | Respiratory CS = 33.5% |
CS (41%) | PS = 34.5% |
NS (35%) | NS = 25.9% |
Wound infection
|
CS = 3.7% |
PS = 2.6% |
NS = 0.6% |
|
Warner et al, 198940 | Coronary artery bypass graft (CABG) | 192 | PS (69%) | 96 days | Yes | Yes | Smokers quitting <2 months before surgery had a 4× increased risk of pulmonary complications than those quit >2 months before surgery. Smokers who stopped smoking >6 months before surgery had the same risk of complications as NS |
Total PCs
|
<2 mths | <2 months = 57.1% |
>2 mths | >8 weeks = 11.8% |
CS (9%) | >6 months = 11.1% |
NS (22%) | CS = 33% |
NS = 11.9% |
Woehlck et al, 199917 | Non-emergency, non-cardiac and non-major vascular surgery | 740 | PS data included in with NS (62%) | Not stated | No | Yes | CS had more complications than PS or NS |
Data unobtainable
|
CS (37%)† |
Yamashita et al, 200441 | Minor | 1008 | PS (37%) <1 wk | 30 days or up to discharge | Yes | No | CS and PS significantly more likely to have increased intraoperative sputum volume than NS. No significant differences in postoperative complications between PS, CS and NS |
Increased sputum; RR (95% CI)
|
>1 wk <2 wks >2 wks <2 mths | <1 wk = 22.9%; 2.4 (1.6 to 3.6) |
>2 mths CS (16%) | <2 wks = 22.9%; 2.4 (1.2 to 4.8) |
NS (48%) | <2 mths = 18.8%; 2.0 (0.9 to 4.3) |
| >2 mths = 11.0%; 1.2 (0.7 to 2.0) |
| CS = 18.2%; 1.9 (1.3 to 3.0) |
| NS = 9.3% 1.0 |
Total PCs
|
>24 hours = 1.4% |
CS = 1.9% |
NS = 1.7% |